HAMILTON CHRISTINE E 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-16 4:33 pm Purchase | 2022-12-07 | 13D | SAB Biotherapeutics, Inc. SABS | HAMILTON CHRISTINE E | 871,205 17.300% | 9,880 (+1.15%) | Filing |
| 2022-09-08 5:04 pm Sale | 2022-06-07 | 13D | SAB Biotherapeutics, Inc. SABS | HAMILTON CHRISTINE E | 861,324 20.000% | -207,274 (-19.40%) | Filing |
| 2021-11-01 4:57 pm Purchase | 2021-10-22 | 13D | SAB Biotherapeutics, Inc. SABS | HAMILTON CHRISTINE E | 1,068,598 24.580% | 1,068,598 (New Position) | Filing |